| Session Introduction | |||||
|
Tue4 Oct11:05am(5 mins)
|
|
Dr Anna Morgan |
|
Dr Simon Pitchford | |
|
Session : Drug Discovery and Development in COPD
Room: Auditorium 4
|
|||||
| The burden of unmet needs in COPD | |||||
|
Tue4 Oct11:10am(30 mins)
|
|
Prof Wisia Wedzicha | |||
|
Session : Drug Discovery and Development in COPD
Room: Auditorium 4
|
|||||
| Novel drug targets in COPD | |||||
|
Tue4 Oct11:40am(30 mins)
|
|
Prof Ian Adcock | |||
|
Session : Drug Discovery and Development in COPD
Room: Auditorium 4
|
|||||
| New perspectives for modelling inflammatory diseases using patient-derived organoids | |||||
|
Tue4 Oct12:10pm(5 mins)
|
|
Dr Sylvia F. Boj | |||
|
Session : Drug Discovery and Development in COPD
Room: Auditorium 4
|
|||||
| Use of Imaging for preclinical evaluation of drugs for the treatment of COPD | |||||
|
Tue4 Oct12:15pm(30 mins)
|
|
Dr Anna Morgan | |||
|
Session : Drug Discovery and Development in COPD
Room: Auditorium 4
|
|||||
| Preclinical translational models for investigating drugs for the treatment of COPD | |||||
|
Tue4 Oct02:00pm(30 mins)
|
|
Dr Simon Pitchford | |||
|
Session : Drug Discovery and Development in COPD
Room: Auditorium 4
|
|||||
| Use of human tissues to investigate drugs for the treatment of COPD | |||||
|
Tue4 Oct02:30pm(30 mins)
|
|
Prof Luigino Calzetta | |||
|
Session : Drug Discovery and Development in COPD
Room: Auditorium 4
|
|||||
| Early experimental medicine studies for investigating new drugs for COPD | |||||
|
Tue4 Oct03:45pm(30 mins)
|
|
Prof Dave Singh | |||
|
Session : Drug Discovery and Development in COPD
Room: Auditorium 4
|
|||||
| Methods to tackle novel molecular targets involved in inflammatory disease | |||||
|
Tue4 Oct04:15pm(15 mins)
|
|
Dr Mark Abbott | |||
|
Session : Drug Discovery and Development in COPD
Room: Auditorium 4
|
|||||
| Publishing in the British Journal of Pharmacology | |||||
|
Tue4 Oct04:30pm(30 mins)
|
|
Mr Charles Whalley | |||
|
Session : Drug Discovery and Development in COPD
Room: Auditorium 4
|
|||||
| Session Introduction | |||||
|
Wed5 Oct11:00am(5 mins)
|
|
Martin Swarbrick |
|
Dr Mary Wheldon | |
|
Prof A Ganesan |
|
Mrs Becky Garton | ||
|
Room: Auditorium 4
|
|||||
| Platforms for the generation and high-throughput screening of cyclic peptide libraries. | |||||
|
Wed5 Oct11:05am(30 mins)
|
|
Prof Ali Tavassoli | |||
|
Room: Auditorium 4
|
|||||
| Green Chemistry at GSK - How and when to use guides, and using Green Chemistry to design a scalable route to a first-in-class BET BD2 inhibitor | |||||
|
Wed5 Oct11:35am(30 mins)
|
|
Mrs Catherine Alder | |||
|
Room: Auditorium 4
|
|||||
| Ligand discovery in dark chemical space leading to biological insights | |||||
|
Wed5 Oct12:05pm(30 mins)
|
|
Dr John Irwin | |||
|
Room: Auditorium 4
|
|||||
| Oxford Nanopore Technologies - a look into the complete genome | |||||
|
Wed5 Oct12:35pm(15 mins)
|
|
Mr Daniel Fordham | |||
|
Room: Auditorium 4
|
|||||
| Discovery of the clinical candidate, ASTX029, a dual mechanism ERK inhibitor | |||||
|
Wed5 Oct02:00pm(30 mins)
|
|
Dr Nicola Wallis | |||
|
Room: Auditorium 4
|
|||||
| Flow Induced Dispersion Analysis (FIDA) Protein QC: Linking absolute hydrodynamic radius determination to structural insight. | |||||
|
Wed5 Oct02:30pm(5 mins)
|
|
Mrs Joanne Walter | |||
|
Room: Auditorium 4
|
|||||
| TargetMol：Targets small molecules in drug discovery | |||||
|
Wed5 Oct02:35pm(5 mins)
|
|
Ms Phoebe Feng | |||
|
Room: Auditorium 4
|
|||||
| The Discovery and Clinical Efficacy of Sisunatovir | |||||
|
Wed5 Oct02:40pm(30 mins)
|
|
Dr Stuart Cockerill | |||
|
Room: Auditorium 4
|
|||||
| Discovery and Development of Pyrukynd®: The First-in-Class Pyruvate Kinase Activator For The Treatment of Hemolytic Anemia | |||||
|
Wed5 Oct03:45pm(30 mins)
|
|
Dr Lenny Dang | |||
|
Room: Auditorium 4
|
|||||
| Simplifying Synthesis with Electricity | |||||
|
Wed5 Oct04:15pm(45 mins)
|
|
Prof Phil Baran | |||
|
Room: Auditorium 4
|
|||||
